NorthWest Biotherapeutics Inc (NWBO)

[Flexroy]

"Unexpectedly it has been determined that activated dendritic cells which produce certain amounts, or threshold amounts, of IL-6, IL-8, IL-12 and/or TNFa have a level of immunotherapeutic potency that correlates with improved clinical outcome, measured by such characteristics as increased survival time and/or increase time to cancer recurrence. As such, activated dendritic cells which produce above the threshold amounts of IL-6, IL-8, IL-12 and/or TNFa provide improved compositions for use in administering to a subject and the compositions demonstrate an increased ability to produce a positive clinical outcome."


Some serious bullish signals in that patent file. LETS GO!!